VIENNA, Austria, Nov. 28, 2025 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today announced that its European…
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…
The latest batch of Golden Licenses span across diversified sectors namely tech, real estate, and green manufacturing, contributing to economic…
REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…
ADDISON, Texas, Oct. 29, 2025 /PRNewswire/ -- Authentix, a pioneer in Nano Optic Security Feature Technologies, today announced it has…
The Zurich-based company is one of the first Bitcoin-only apps to obtain the MiCA license from the French regulatory body,…
DUBAI, UAE, Oct. 9, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, today announced that it…
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- S3 Partners, the industry leading provider of real-time short interest and securities finance analytics,…
VIENNA, Austria, Sept. 5, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is advancing its European…
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from…